Lost after translation: missorting of Tau protein and consequences for Alzheimer disease

Tau is a microtubule-associated-protein that is sorted into neuronal axons in physiological conditions. In Alzheimer disease (AD) and other tauopathies, Tau sorting mechanisms fail and Tau becomes missorted into the somatodendritic compartment. In AD, aberrant amyloid-β (Aβ) production might trigger Tau missorting. The physiological axonal sorting of Tau depends on the developmental stage of the neuron, the phosphorylation state of Tau and the microtubule cytoskeleton. Disease-associated missorting of Tau is connected to increased phosphorylation and aggregation of Tau, and impaired microtubule interactions. Disease-causing mechanisms involve impaired transport, aberrant kinase activation, non-physiological interactions of Tau, and prion-like spreading. In this review we focus on the physiological and pathological (mis)sorting of Tau, the underlying mechanisms, and effects in disease.

[1]  T. Arendt,et al.  Pattern of tau isoforms expression during development in vivo , 2009, International Journal of Developmental Neuroscience.

[2]  R. Crowther,et al.  Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. , 1989, The EMBO journal.

[3]  D. Holtzman,et al.  Controlled Cortical Impact Traumatic Brain Injury in 3xTg-AD Mice Causes Acute Intra-Axonal Amyloid-β Accumulation and Independently Accelerates the Development of Tau Abnormalities , 2011, The Journal of Neuroscience.

[4]  J. Trojanowski,et al.  Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration , 2005, The Journal of Neuroscience.

[5]  E. Mandelkow,et al.  Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines , 2010, The Journal of Neuroscience.

[6]  Pedro Pesini,et al.  Natural Non-Trasgenic Animal Models for Research in Alzheimer’s Disease , 2009, Current Alzheimer research.

[7]  B. Yankner,et al.  β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.

[8]  Wolfgang Härtig,et al.  Reversible Paired Helical Filament-Like Phosphorylation of Tau Is an Adaptive Process Associated with Neuronal Plasticity in Hibernating Animals , 2003, The Journal of Neuroscience.

[9]  J. Bamburg,et al.  Rapid Changes in Phospho-MAP/Tau Epitopes during Neuronal Stress: Cofilin-Actin Rods Primarily Recruit Microtubule Binding Domain Epitopes , 2011, PloS one.

[10]  M. Mattson Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD , 1995, Neurobiology of Aging.

[11]  A. Delacourte,et al.  Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease , 1999, Brain pathology.

[12]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[13]  F. LaFerla,et al.  p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice , 2014, Neuroscience Letters.

[14]  Meaghan Morris,et al.  The Many Faces of Tau , 2011, Neuron.

[15]  N. Hirokawa,et al.  Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.

[16]  H. Braak,et al.  Alzheimer’s disease: intraneuronal alterations precede insoluble amyloid-β formation , 2004, Neurobiology of Aging.

[17]  B. Lu,et al.  PAR-1 Kinase Plays an Initiator Role in a Temporally Ordered Phosphorylation Process that Confers Tau Toxicity in Drosophila , 2004, Cell.

[18]  Jian-Zhi Wang,et al.  Protein Phosphatase 2A Facilitates Axonogenesis by Dephosphorylating CRMP2 , 2010, The Journal of Neuroscience.

[19]  Adriana B Ferreira,et al.  The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced Neurodegeneration , 2005, The Journal of Neuroscience.

[20]  K. Kosik,et al.  Phosphorylated tau and the neurodegenerative foldopathies. , 2005, Biochimica et biophysica acta.

[21]  M. Kirschner,et al.  Tau protein function in living cells , 1986, The Journal of cell biology.

[22]  M. Goedert,et al.  Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. , 1995, The EMBO journal.

[23]  B. Ghetti,et al.  Frontotemporal dementia: implications for understanding Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[24]  A. Frankfurter,et al.  Differential Localization of MAP‐2 and Tau in Mammalian Neurons in Situ a , 1986, Annals of the New York Academy of Sciences.

[25]  N. Hirokawa,et al.  Sorting mechanisms of Tau and MAP2 in neurons: Suppressed axonal transit of MAP2 and locally regulated microtubule binding , 1995, Neuron.

[26]  Patrizia LoPresti,et al.  Truncated Tau with the Fyn‐binding domain and without the microtubule‐binding domain hinders the myelinating capacity of an oligodendrocyte cell line , 2008, Journal of neurochemistry.

[27]  P. Lantos,et al.  Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.

[28]  Min Jae Lee,et al.  Tau degradation: The ubiquitin–proteasome system versus the autophagy-lysosome system , 2013, Progress in Neurobiology.

[29]  L. Behar,et al.  Axonal Tau mRNA Localization Coincides with Tau Protein in Living Neuronal Cells and Depends on Axonal Targeting Signal , 2001, The Journal of Neuroscience.

[30]  M. Spillantini,et al.  Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations , 2007, Brain pathology.

[31]  Wendy Noble,et al.  Physiological release of endogenous tau is stimulated by neuronal activity , 2013, EMBO reports.

[32]  M. Kirschner,et al.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. , 1977, Journal of molecular biology.

[33]  J. Sanes,et al.  Mammalian SAD Kinases Are Required for Neuronal Polarization , 2005, Science.

[34]  R. D'Hooge,et al.  Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau , 2012, Acta Neuropathologica.

[35]  S. Halpain,et al.  The MAP2/Tau family of microtubule-associated proteins , 2004, Genome Biology.

[36]  J. Trojanowski,et al.  The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice , 2012, The Journal of Neuroscience.

[37]  Linda Partridge,et al.  Inhibition of GSK-3 Ameliorates Aβ Pathology in an Adult-Onset Drosophila Model of Alzheimer's Disease , 2010, PLoS genetics.

[38]  D. Gerlich,et al.  Tubulin polyglutamylation stimulates spastin-mediated microtubule severing , 2010, The Journal of cell biology.

[39]  Wen-Lang Lin,et al.  Deletion of the Ubiquitin Ligase CHIP Leads to the Accumulation, But Not the Aggregation, of Both Endogenous Phospho- and Caspase-3-Cleaved Tau Species , 2006, The Journal of Neuroscience.

[40]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[41]  Bruce S. McEwen,et al.  Rapid and reversible changes in intrahippocampal connectivity during the course of hibernation in European hamsters , 2006, Proceedings of the National Academy of Sciences.

[42]  D. Holtzman,et al.  Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury. , 2012, Brain : a journal of neurology.

[43]  R. Nelson,et al.  Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia , 2007, The Journal of Neuroscience.

[44]  S. Andrews,et al.  Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a “P301L” tau knockin mouse , 2012, Neurobiology of Aging.

[45]  K. Kosik,et al.  Selective Phosphorylation of Adult Tau Isoforms in Mature Hippocampal Neurons Exposed to Fibrillar Aβ , 1997, Molecular and Cellular Neuroscience.

[46]  George Perry,et al.  Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. , 2003, The American journal of pathology.

[47]  E. Mandelkow,et al.  Amyloid‐β oligomers induce synaptic damage via Tau‐dependent microtubule severing by TTLL6 and spastin , 2013, The EMBO journal.

[48]  H. Neumann,et al.  Accumulation of tau induced in neurites by microglial proinflammatory mediators , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  N. Hirokawa,et al.  Selective stabilization of tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons , 1996, The Journal of cell biology.

[50]  T. Ben-Hur,et al.  A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics , 2008, Experimental Neurology.

[51]  E. Mandelkow,et al.  Missorting of Tau in Neurons Causes Degeneration of Synapses That Can Be Rescued by the Kinase MARK2/Par-1 , 2007, The Journal of Neuroscience.

[52]  J. Götz,et al.  Profiling Murine Tau with 0N, 1N and 2N Isoform-Specific Antibodies in Brain and Peripheral Organs Reveals Distinct Subcellular Localization, with the 1N Isoform Being Enriched in the Nucleus , 2013, PloS one.

[53]  L. Buée,et al.  Nuclear Tau, a Key Player in Neuronal DNA Protection* , 2010, The Journal of Biological Chemistry.

[54]  M. Mesulam,et al.  The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy , 2003, Acta Neuropathologica.

[55]  A. Ittner,et al.  Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice , 2011, PloS one.

[56]  Blaine R. Roberts,et al.  Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export , 2012, Nature Medicine.

[57]  B. Hyman,et al.  Mechanisms of protein seeding in neurodegenerative diseases. , 2013, JAMA neurology.

[58]  Rudi D'Hooge,et al.  Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant , 2011, The Journal of Neuroscience.

[59]  D. Holtzman,et al.  Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo , 2013, Neuron.

[60]  Cornelia M. Wilson,et al.  Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A , 2013, Ageing Research Reviews.

[61]  A. Erisir,et al.  Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid , 2006, The Journal of cell biology.

[62]  Menno P. Witter,et al.  Trans-Synaptic Spread of Tau Pathology In Vivo , 2012, PloS one.

[63]  P. Davies,et al.  Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology , 2009, The Journal of Neuroscience.

[64]  Naruhiko Sahara,et al.  Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.

[65]  H. Braak,et al.  Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? , 2011, Acta Neuropathologica.

[66]  J. Gallo,et al.  Tau alternative splicing in familial and sporadic tauopathies. , 2012, Biochemical Society transactions.

[67]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[68]  E. Mandelkow,et al.  Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. , 1999, Biochemistry.

[69]  D. Wilcock,et al.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.

[70]  Christian Griesinger,et al.  Structural Polymorphism of 441-Residue Tau at Single Residue Resolution , 2009, PLoS biology.

[71]  Christian Wider,et al.  Etiology and Pathophysiology of Frontotemporal Dementia, Parkinson Disease and Alzheimer Disease: Lessons from Genetic Studies , 2008, Neurodegenerative Diseases.

[72]  M. Mercken,et al.  Three distinct axonal transport rates for tau, tubulin, and other microtubule-associated proteins: evidence for dynamic interactions of tau with microtubules in vivo , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[73]  K. Ashe,et al.  Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.

[74]  J. Götz,et al.  Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.

[75]  Dennis W. Dickson,et al.  Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau) , 2011, Journal of Molecular Neuroscience.

[76]  M. Diamond,et al.  Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.

[77]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[78]  C. Hoogenraad,et al.  Maintenance of Dendritic Spine Morphology by Partitioning-Defective 1b through Regulation of Microtubule Growth , 2011, The Journal of Neuroscience.

[79]  H. Steinhoff,et al.  Microtubule Binding and Trapping at the Tip of Neurites Regulate Tau Motion in Living Neurons , 2009, Traffic.

[80]  C. Richter-Landsberg The Cytoskeleton in Oligodendrocytes , 2008, Journal of Molecular Neuroscience.

[81]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[82]  Brian J. Bacskai,et al.  Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo , 2013, Proceedings of the National Academy of Sciences.

[83]  K. Blennow,et al.  The Neuropathology and Neurobiology of Traumatic Brain Injury , 2012, Neuron.

[84]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[85]  Matthew N. Rasband,et al.  The axon initial segment and the maintenance of neuronal polarity , 2010, Nature Reviews Neuroscience.

[86]  P. Baas,et al.  Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases. , 2011, Human molecular genetics.

[87]  Carsten Janke,et al.  Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton , 2010, Trends in Neurosciences.

[88]  F. van Leuven,et al.  Early Improved and Late Defective Cognition Is Reflected by Dendritic Spines in Tau.P301L Mice , 2011, The Journal of Neuroscience.

[89]  A. Takashima,et al.  Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild‐type human tau , 2007, The EMBO journal.

[90]  S. Kaech,et al.  Culturing hippocampal neurons , 2006, Nature Protocols.

[91]  E. Mandelkow,et al.  Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy , 2006, Journal of Biological Chemistry.

[92]  E. Mandelkow,et al.  MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons , 2004, The Journal of cell biology.

[93]  E. Mandelkow,et al.  The tau of MARK: a polarized view of the cytoskeleton. , 2009, Trends in biochemical sciences.

[94]  N. Hirokawa,et al.  Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice , 2000, Neuroscience Letters.

[95]  D. Dickson,et al.  Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration. , 2009, The American journal of pathology.

[96]  A. Andreadis Tau splicing and the intricacies of dementia , 2012, Journal of Cellular Physiology.

[97]  L. Mucke,et al.  Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[98]  Jianhua Shi,et al.  PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. , 2010, Journal of Alzheimer's disease : JAD.

[99]  B. Riederer,et al.  Microtubule-associated protein 1B, a growth-associated and phosphorylated scaffold protein , 2007, Brain Research Bulletin.

[100]  Martin Beibel,et al.  Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.

[101]  Brian M. Barnes,et al.  The Physiological Link between Metabolic Rate Depression and Tau Phosphorylation in Mammalian Hibernation , 2011, PloS one.

[102]  F. van Leuven,et al.  Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice* , 2005, Journal of Biological Chemistry.

[103]  R. Neve,et al.  Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. , 1986, Brain research.

[104]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[105]  Defects in Axonal Elongation and Neuronal Migration in Mice with Disrupted tau and map1b Genes , 2000, The Journal of cell biology.

[106]  E. Mandelkow,et al.  Biochemistry and cell biology of tau protein in neurofibrillary degeneration. , 2012, Cold Spring Harbor perspectives in medicine.

[107]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[108]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[109]  D. Holtzman,et al.  In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice , 2011, The Journal of Neuroscience.

[110]  Bin Zhang,et al.  Axonal Degeneration Induced by Targeted Expression of Mutant Human Tau in Oligodendrocytes of Transgenic Mice That Model Glial Tauopathies , 2005, The Journal of Neuroscience.

[111]  F. LaFerla,et al.  Reduction of Soluble Aβ and Tau, but Not Soluble Aβ Alone, Ameliorates Cognitive Decline in Transgenic Mice with Plaques and Tangles* , 2006, Journal of Biological Chemistry.

[112]  E. Mandelkow,et al.  Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration , 2011, The EMBO journal.

[113]  Frank Bradke,et al.  Control of neuronal polarity and plasticity--a renaissance for microtubules? , 2009, Trends in cell biology.

[114]  E. Mandelkow,et al.  Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment , 2011, Neurobiology of Aging.

[115]  E. Mandelkow,et al.  Microtubule Affinity Regulating Kinase Activity in Living Neurons Was Examined by a Genetically Encoded Fluorescence Resonance Energy Transfer/Fluorescence Lifetime Imaging-based Biosensor , 2011, The Journal of Biological Chemistry.

[116]  E. Mandelkow,et al.  Swimming against the Tide: Mobility of the Microtubule-Associated Protein Tau in Neurons , 2007, The Journal of Neuroscience.

[117]  O. Lindvall,et al.  Research in motion: the enigma of Parkinson's disease pathology spread , 2008, Nature Reviews Neuroscience.

[118]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[119]  J. Trojanowski,et al.  Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of Tauopathy , 2011, The Journal of Neuroscience.

[120]  Frank M LaFerla,et al.  Animal models of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[121]  U. Sengupta,et al.  Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau , 2012, Scientific Reports.

[122]  W. Noble,et al.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. , 2009, Trends in molecular medicine.

[123]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[124]  J. Mandell,et al.  The microtubule cytoskeleton and the development of neuronal polarity , 1995, Neurobiology of Aging.

[125]  E. Mandelkow,et al.  Degradation of tau protein by autophagy and proteasomal pathways. , 2012, Biochemical Society transactions.

[126]  C. Haass,et al.  Loss of fused in sarcoma (FUS) promotes pathological Tau splicing , 2012, EMBO reports.

[127]  A. Lees,et al.  The Slow Axonal Transport of the Microtubule-Associated Protein Tau and the Transport Rates of Different Isoforms and Mutants in Cultured Neurons , 2002, The Journal of Neuroscience.

[128]  M. Vitek,et al.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.

[129]  Tsuyoshi Morita,et al.  Specification of Neuronal Polarity Regulated by Local Translation of CRMP2 and Tau via the mTOR-p70S6K Pathway* , 2009, The Journal of Biological Chemistry.